OnKure Historical Income Statement
| OKUR Stock | 8.38 0.33 4.10% |
Historical analysis of OnKure Therapeutics, income statement accounts such as Total Revenue of 0.0 can show how well OnKure Therapeutics, performed in making a profits. Evaluating OnKure Therapeutics, income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of OnKure Therapeutics,'s future profits or losses.
OnKure |
About OnKure Income Statement Analysis
OnKure Therapeutics, Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to OnKure Therapeutics, shareholders. The income statement also shows OnKure investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
OnKure Therapeutics, Income Statement Chart
Total Revenue
Total revenue comprises all receipts OnKure Therapeutics, generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on OnKure Therapeutics, income statement and is an important metric when analyzing OnKure Therapeutics, profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in OnKure Therapeutics, financial statement analysis. It represents the amount of money remaining after all of OnKure Therapeutics, operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from OnKure Therapeutics,'s income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into OnKure Therapeutics, current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OnKure Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in OnKure Stock, please use our How to Invest in OnKure Therapeutics, guide.
| 2010 | 2023 | 2024 (projected) | Interest Income | 254K | 1.6M | 1.0M | Net Interest Income | 254K | 1.6M | 1.0M |
OnKure Therapeutics, income statement Correlations
Click cells to compare fundamentals
OnKure Therapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.76 | EVLO | Evelo Biosciences | PairCorr |
| 0.72 | VAXX | Vaxxinity | PairCorr |
| 0.67 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.66 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.59 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.